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Objectives: to assess the efficacy of recombinant human manganese superoxide dismutase (rhMnSOD) in prevention of
early and late skeletal muscle ischaemia-reperfusion injury mediated by superoxide (O2-).
Design: randomised controlled trial.
Materials: seventy-two Sprague–Dawley rats (250–350 g) randomised to receive either 7.5 mg/kg of rhMnSOD or saline.
Four hours of ischaemia was induced in the cremaster muscle by dissecting free and clamping its vascular supply.
Cremaster muscle contractile function was assessed following 90 minutes, 24, 48 hours and one week of reperfusion.
Electrophysiological muscle function was assessed using electrical field stimulation in an organ bath system.
Results: muscle function in the untreated groups following ischaemia reperfusion was significantly reduced at 90 minutes,
24, 48 hours and one week of reperfusion (p<0.05). rhMnSOD significantly protected and maintained normal muscle
function at 24 and 48 hours (p<0.001). However at one week of reperfusion there was a reduction in function of the
treated muscle, such that there was no significant difference between treated and untreated muscle at this point in time.
Conclusions: these data demonstrate that skeletal muscle dysfunction after ischaemia reperfusion injury is attenuated at
24 and 48 hrs of reperfusion by the superoxide scavenger rhMnSOD. This protective effect is not maintained after seven
days of reperfusion.
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Introduction injury.7,8 The xanthine oxidase reaction pathway has
been identified as the most important pathway of
Reperfusion injury following prolonged ischaemia is oxygen-derived free radical9 production during the
reperfusion phase.5well described in most tissues. In the clinical setting,
ischaemia reperfusion injury has been shown to occur Superoxide (O2-), hydrogen peroxide (H2O2) and
hydroxyl (OH-) are the most important xanthine ox-in skeletal muscle following tourniquet application.
Reperfusion injury may be defined as the damage that idase-derived free radicals. Superoxide is generated
by adding one electron to the oxygen molecule. Itoccurs to an organ during reflow after an episode of
ischaemia.1 Reperfusion of the lower extremity con- is a by-product of normal metabolism and is also
synthesised from hypoxanthine in a reaction catalysedtinues to have a significant morbidity and mortality.2
Major amputation is required in up to 30 per cent of by xanthine oxidase. During normal metabolism,
superoxide is immediately degraded to hydrogen per-patients undergoing surgery for acute limb ischaemia3
and skeletal muscle reperfusion injury contributes sig- oxide and oxygen, usually by the action of superoxide
dismutase (SOD). Hydrogen peroxide is further de-nificantly to this.4
Hypoxic perfusion of ischaemic tissue causes very graded to water and oxygen by the action of catalase.
The reactions involved in the production of free rad-little injury. The return of oxygenated blood to the
ischaemic tissue, however, initiates a reaction that icals are closely related.
The free radical scavenging function of SOD wasfurther injures the tissue.5,6 Several studies have iden-
tified oxygen-derived free radicals as the mediators of discovered by McCord and Fridovich in 1969.10 There
are at least three different isoenzymes of SOD whichthe reperfusion component of ischaemia-reperfusion
occur in mammals. Recombinant human manganese
superoxide dismutase (rhMnSOD), was isolated in* Please address all correspondence to: D. Bouchier-Hayes, De-
partment of Surgery, Beaumont Hospital, Dublin 9, Ireland. 197711 and is distinct from its Cu/ZnSOD counterparts
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in that it has a longer plasma half-life (5.5 to 7.3 hours) and the muscle was then opened with microsurgical
scissors on the less-vascular ventral plane, taking carethan other types of SOD (7 to 12 minutes).12 Previous
studies have shown that rhMnSOD-treated skeletal to avoid the larger anastomosing vessels.
The main testicular blood vessels were freed bymuscle demonstrates preservation of contractile
strength after 90 minutes’ reperfusion following an dissecting the connective tissue proximally and down
to the proximal end of the muscle pouch. The vesselsischaemic insult.13 The aim of this study was to assess
whether this protection of muscle function was present between the testis and the cremaster muscle were
cauterised and divided. The meso-epididymis andat the clinically relevant times of 24 and 48 hours and
one week post reperfusion. testicular vessels were tied off and cut with scissors
freeing the testis and epididymis, which was dis-
carded. The neck of the cremaster muscle was cut
circumferentially to completely isolate the muscle ex-
Materials and Methods cept by a pedicle containing the cremasteric artery and
vein as well as the nerves to the muscle.
Experimental design Complete ischaemia was induced for 4 hours by
placing a microclamp across the pedicle. The pre-
In vitro studies were performed on the cremaster paration was covered with a moistened swab of warm
muscle of seventy-two male Sprague–Dawley rodents, Kreb’s solution to protect the muscle from drying out.
weighing between 250–350 g (Oterling OC61, Avery At the end of the 4-hour ischaemia time, the mi-
Berkel, Warley, U.K.). The rodents were cared for croclamp was removed. In those groups undergoing
according to the principles of laboratory animal care reperfusion of 24 hours or longer, the right cremaster
in Ireland. The animals had free access to food and muscle was carefully placed in the abdominal cavity
water at all times, i.e. before the experiments as well via the superficial inguinal ring and scrotum closed
as during the reperfusion period when appropriate. with 3/0 nylon sutures. The animals were allowed to
The animals were randomly divided into nine groups. awaken and returned to their cages.
The duration of reperfusion was 90 minutes, 24 and
48 hours and finally 7 days, with both treated and
untreated groups at each of the reperfusion times. The
Assessment of muscle function using electrical fieldtreated groups were given rhMnSOD in 1 ml of saline
stimulationintraperitoneally at the onset of ischaemia. rhMnSOD
(BioTechnology General, Israel12) was dissolved in sa-
The cremaster muscle was isolated as described above.line (2.5 mg/ml) before administration. A dose of
The animals that underwent reperfusion for 24 hours,7.5 mg/kg of rhMnSOD was used (1 mg=4000 IU).
48 hours or 7 days were anaesthetised as before. The
sutures were removed from the right scrotum and the
incision extended proximally onto the lower ab-
dominal wall. The cremaster muscle was opened outOperative isolation of the cremaster muscle14
with the minimum of handling and prepared for ana-
lysis as described below.The rat cremaster model was first described by Majno
and Palade in 196115 as a means of visualising the A section of muscle (2.5 by 0.5 cm) was carefully
excised from a standard central area using micro-microcirculation in vivo. This model was used prim-
arily because it allows simple but complete neuro- surgical scissors. A 4/0 silk suture was secured to the
end of the strip of muscle in situ. Once this was invascular isolation of true skeletal muscle and the
surgery to the animal was minimal, allowing consistent place, the muscle strip was freshly excised. The other
end was fixed to an isometric force transducer with asurvival of the animals postoperatively of up to a
week. The animals were anaesthetised with inhala- tissue clip (Radnoti Glass Technology Inc., CA, U.S.A.).
The muscle strip was mounted with its long axistional halothane. They were placed supine on the table
and the temperature was maintained by a heating in the vertical plane and suspended between two
platinum electrodes set vertically approximately 1 cmlamp and monitored using a rectal thermometer. The
scrotum and groin was gently shaved and cleansed. apart (Radnoti Glass Technology Inc.). This was
lowered into a 50-ml water-jacketed glass tissueA 1–2-cm longitudinal incision of the skin and fascia
was made on the ventral aspect of the (right) scrotum. chamber (Radnoti Glass Technology Inc.). The trans-
ducer was fixed to a retort stand via a transducerThe remaining connective tissue was carefully sep-
arated by blunt dissection from the cremaster sac micropositioner (Radnoti Glass Technology Inc.) which
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allowed adjustment of the pre-load tension on the
muscle. The transducer was used in conjunction with
a built-in amplifier with an effective range of 0–20 g.
The cremaster muscle was maintained in Krebs–Ringer
bicarbonate buffer solution (Sigma Chemical Co. Ltd.,
Irvine, U.K.). The solution was adjusted so that its pH
was 7.3–7.4 and this was maintained, as well as the
oxygen saturation, by constantly aerating the solution
with 95% O2/5% CO2 (BOC Gases, Dublin, Ireland).
The temperature was maintained at 37 °C by circu-
lating warm water through the outer jacket of the
tissue chamber (Cole Palmer Immersion Circulator
via Foss Electric, Dublin, Ireland). The muscle was































along the whole length of the muscle. Supramaximal
Fig. 1. Results of twitch contractions. (F) Control; (D) untreated;pulses (20 V, 2 ms squarewave duration16–18 and 40 Hz) (E) rhMnSOD. * p<0.05 vs. control. † p<0.001 vs. untreated.
were obtained from a pulse generator (Harvard stim-
ulator, Harvard Apparatus, Kent, U.K.).
Muscle length was adjusted to that at which twitch
isometric force production was maximal (i.e. optimal
fibre bundle length). Electrical field stimulation was
then performed. The isometric contraction of each
muscle strip was assessed in response to a timed series
of twitch and tetanic electrical stimuli. The muscle
strip was then weighed (Oertling YA124 Analytical
Balance, Avery Berkel, Warley, U.K.). The animals were
euthanased with a lethal intracardial dose of sodium
pentobarbitone (SagatalÌ).





























Muscle contractile force was measured using a force
Fig. 2. Results of tetanus contractions. (F) Control; (D) untreated;
transducer, a commercially available computerised (E) rhMnSOD. * p<0.05 vs. control. † p<0.001 vs. untreated.
data acquisition program (MacLabTM/2e Chart and
Scope, AD Instruments Ltd, U.K.) and stored directly
onto the hard drive of a computer (Macintosh Power- for both twitch and tetanus contractions. The results
Book 160). The above computer program was later were expressed per gram of muscle used for each
used off-line to analyse the tension data. Calibration contractility assessment. Peak twitch and tetanus were
of the force transducer was performed by hanging compared between rhMnSOD-treated and untreated
known weights from the transducer. Data were col- groups at the same reperfusion times.
lected in standard microcomputer spreadsheets and
analysed using Data Desk 5.0.1 (Data Description Inc.,
New York, U.S.A.). Table 1. The nine groups used in the experiments.
The statistical significance of the data was assessed Group Ischaemia (hours) n Reperfusion Treatment
by analysis of variance (ANOVA) followed by Scheffe’s
Controls None 8 None Nonepost hoc test. The significance was set at p<0.05.
Group 1 4 8 90 minutes Untreated
Group 2 4 8 90 minutes Treated
Group 3 4 8 24 hours Untreated
Group 4 4 8 24 hours Treated
Results (Figs 1, 2) Group 5 4 8 48 hours Untreated
Group 6 4 8 48 hours Treated
Group 7 4 8 7 days UntreatedMuscle contractile function was expressed as the peak
Group 8 4 8 7 days Treated
tension (in grams of “force”) achieved by each muscle
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Untreated groups treatment would preserve muscle in the short and
long term.
Muscle twitch and tetanus contractility in the untreated In our study, 4 hours of ischaemia followed by
groups was significantly reduced following ischaemia reperfusion resulted in a decrease in muscle function.
and 90 minutes, 24, 48 hours and one week reperfusion rhMnSOD was not functionally protective at 90 min-
compared with controls (p<0.05). Twitch results in the utes. After 24 and 48 hours of reperfusion, rhMnSOD-
untreated groups were 52.71 g, 21.83 g, 33.99 g, and treated muscle functioned significantly better than
77.14 g at 90 min, 24 h, 48 h and one week, respectively. untreated muscle. rhMnSOD also maintained normal
Tetanus results in the untreated group were 277.48 g, muscle function at these time points as compared to
112.42 g, 136.63 g, and 162.58 g at 90 min, 24 h, 48 h controls, with the exception of twitch function at 24 h.
and one week, respectively. Control muscle twitch and However, after one week of reperfusion, none of this
tetanus results were 133.9 g and 482.62 g respectively. functional benefit was present.
O’Farrell has previously shown that rhMnSOD at-
tenuates muscle reperfusion injury when administered
intravenously after 5 hours’ ischaemia and 90 minutes’
rhMnSOD-treated group reperfusion, using contractility as well as creatinine
phosphokinase and fluorescein dye perfusion studies.13
At 90 minutes, the rhMnSOD-treated groups failed to A synthetic form of SOD with a serum half-life of two
show a significant protective effect over the untreated hours has been shown to reduce reperfusion injury in
groups with twitch function being 47.91 g and tetanus rabbit femoris muscle following 4 hours’ ischaemia
function being 232.3 g (twitch, p=0.87 and tetanus, and 24 hours of reperfusion, thus supporting our own
p=0.65). As part of an initial dose-response study, a findings.19
lower dose of 1.5 mg/kg of rhMnSOD (6000 IU), given These differences may be explained by the shorter
at two reperfusion times (six in each group), namely ischaemic time and an intraperitoneal (i.p.) route of
24 and 48 hours, also failed to show any attenuation administration used in this study in contrast to the
at either time periods, in both twitch and tetanus. intravenous route used in the previous study. Nimrod
On giving a higher dose of rhMnSOD, 7.5 mg/kg and his co-workers have previously shown that the
(30 000 IU), there was a significant attenuation of both plasma half-life of the i.v. versus the i.p. route is 6.2
muscle twitch and tetanus contractility in those
vs. 5.5 hours, respectively.12 In addition, the peakrhMnSOD-treated groups at both 24 and 48 h (p<0.001).
serum level reached by the i.v. route was 430 lg/mlTwitch function was 70.47 g at 24 h and 110.02 g at
(dose 25 mg/ml) compared with peak serum levels of48 h. Tetanus function was 348.33 g and 434.94 g at
120 lg/ml reached 2 hours in after-i.p. administration.24 h and 48 h, respectively. The muscle function at 24
We administered rhMnSOD prior to ischaemia so thatand 48 h with the exception of twitch function at 24 h
peak plasma levels could be reached at the point ofwas not significantly different from control muscle
reperfusion. During initial pilot studies we found that(p<0.05). This attenuation of reperfusion injury was
a dose of 1.5 mg/kg was insufficient to prevent re-lost after one week’s reperfusion with muscle function
perfusion injury in the muscle. The higher dose ofresults being 91.5 g and 260.72 g for twitch and tetanus
7.5 mg/kg was therefore used and had a protectiverespectively (twitch, p=0.53 and tetanus, p=0.21).
effect at both 24 and 48 hours.Therefore, irrespective of whether rhMnSOD treat-
The assessment time points chosen in this studyment was given, or not given, in rats subjected to
were 90 min, 24 h, 48 h and one week. Previous at-ischaemia reperfusion, there were no differences in
tempts have used a variety of treatments, mainlyelectrophysiological skeletal muscle function at one
anti-oxidant-based, to protect skeletal muscle againstweek of reperfusion. Both treated and untreated isch-
ultrastructural and functional changes associated withaemia reperfusion groups also failed to maintain nor-
I-R injury. Therapeutic agents have included super-mal function as compared with controls (p<0.05).
oxide dismutase, allopurinol and catalase.13,20 In ad-
dition, ischaemic preconditioning has been used to
prevent cardiac and skeletal muscle from I-R injury.21–23
None of the previous studies, through looking at onlyDiscussion
structural changes, or early (90 min–24 h) functional
sampling time points, have shown, or protectedOur hypothesis was that ischaemia-reperfusion (I-R)
against, the late (1 week) skeletal muscle functionalinjury would result in an O2- free radical-mediated
decrease in contractile function, and that rhMnSOD loss demonstrated in our study.
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